Australia TGA Medical Device Market Entry: September 2025

Medical devices and IVDs generally need to be included in the Australian Register of Therapeutic Goods (ARTG) before they can be supplied in Australia. An effective market-entry plan should connect device classification, conformity assessment evidence, Australian sponsor responsibilities and post-market obligations.

What to review

• Confirm whether the product is regulated as a medical device or IVD and determine its Australian classification.
• Define the Australian sponsor arrangement and clarify the manufacturer’s and sponsor’s regulatory responsibilities.
• Assess whether existing conformity assessment evidence is acceptable and whether a TGA application audit may apply.
• Prepare the ARTG inclusion application, labeling, technical documentation and supporting evidence appropriate to the device class.
• Establish post-market procedures for incident reporting, recalls, corrective actions and regulatory changes.

Practical impact

Manufacturers should assess Australian requirements before finalizing commercial arrangements. Early confirmation of classification, sponsor responsibilities and acceptable conformity assessment evidence can reduce avoidable delays during ARTG inclusion.

Official regulatory resource

Review the TGA guidance for medical devices and IVDs for current market-entry and compliance requirements.